Your Very Humorous SFB
Remember Karma , & The slugs that shorts a cancer drug what it has in store for them ! It Has To Be Hot In That Boiler Room !
Its 181 Mil In cash and poss royalties form J&J under second licensing of patents. With a Fast track Last oct , Poss pending ??? and Poss In EU Approval ?? Regardless Of J&J Business Decision they sent out a very telling signal prior to walking, maybe deliberate ? "Imetelstat Was Approve For a Trial Drug Under "Compassionate Use " Anyone With a Brain Knows FDA Doesn't Pass Them Out !!! Imetelstat Had to Meet a Unmet Need and Certain Strictly Evaluated Criteria to be offered , Its apparent that J&J decision to move on and focus on other business had nothing to do with Imet ! Maybe they figured they have the second licensing agreement for patents and had no need for Geron to remain in first one !
There are a few near term catalyst that can make this a double for here, Or more ! JMHO GLTA
News 
Market Data 
Discover 
